Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study.
Hess A, Tascilar K, Schenker HM, Konerth L, Schönau V, Sergeeva M, Kreitz S, Prade J, Strobelt S, Selvakumar M, Kleyer A, Englbrecht M, Hueber AJ, Zaiss MM, Feist E, Burmester GR, Voll RE, Finzel S, Baerwald C, Rösch J, Behrens F, Koehm M, da Silva JAP, Damjanov N, Dörfler A, Schett G, Rech J.
Hess A, et al. Among authors: schenker hm.
Lancet Rheumatol. 2025 Jun 23:S2665-9913(25)00032-3. doi: 10.1016/S2665-9913(25)00032-3. Online ahead of print.
Lancet Rheumatol. 2025.
PMID: 40570879
Free article.